China NT Pharma Group Company Limited (HKG:1011)

HKG:1011 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	492	71	145	171	135	229
Market Cap Growth	693.09%	-50.91%	-15.27%	26.76%	-40.83%	-27.27%
Enterprise Value	834	445	993	1,082	992	1,420
Last Close Price	0.73	0.27	0.55	0.90	0.71	1.20
Forward PE	-	15.33	15.33	15.33	15.33	15.33
PS Ratio	24.07	1.77	17.90	-	0.49	0.87
PB Ratio	-1.62	-0.17	-0.39	-0.63	-0.52	8.58
P/FCF Ratio	-	-	3.32	4.78	-	81.55
P/OCF Ratio	-	-	2.61	4.19	-	7.34
EV/Sales Ratio	40.80	11.01	122.42	-	3.57	5.39
EV/FCF Ratio	-33.48	-	22.69	30.19	-	506.69
Debt / Equity Ratio	-1.14	-0.94	-1.02	-3.42	-3.94	37.97
Debt / FCF Ratio	-	-	8.68	26.06	-	360.79
Net Debt / Equity Ratio	-1.13	-0.92	-1.01	-3.39	-3.89	37.63
Net Debt / EBITDA Ratio	-26.27	-27.80	-6.65	-87.43	-14.36	-15.99
Net Debt / FCF Ratio	-13.72	-39.63	8.64	25.87	-6.05	357.53
Asset Turnover	0.06	0.11	0.01	-	0.20	0.14
Inventory Turnover	-	-	-	-	2.74	2.81
Quick Ratio	0.05	0.01	0.02	0.05	0.05	0.35
Current Ratio	0.05	0.02	0.02	0.06	0.30	0.50
Return on Equity (ROE)	-	-	-	-	-	-307.64%
Return on Assets (ROA)	-2.18%	-2.49%	-5.26%	-1.69%	-5.19%	-2.95%
Return on Invested Capital (ROIC)	-33.88%	-	-19.29%	-4.46%	-12.65%	-7.60%
Return on Capital Employed (ROCE)	4.30%	3.40%	16.70%	16.20%	-157.40%	-52.70%
Earnings Yield	-15.79%	-79.63%	-108.91%	-43.79%	-135.74%	-185.81%
FCF Yield	-5.06%	-13.80%	30.14%	20.92%	-123.43%	1.23%
Buyback Yield / Dilution	-65.59%	-10.72%	-25.59%	-0.51%	-0.14%	-6.98%
Total Shareholder Return	-65.59%	-10.72%	-25.59%	-0.51%	-0.14%	-6.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.